These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12162700)
21. Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides. Henry SP; Marcusson EG; Vincent TM; Dean NM Trends Pharmacol Sci; 2004 Oct; 25(10):523-7. PubMed ID: 15380936 [TBL] [Abstract][Full Text] [Related]
22. The future of antisense oligonucleotides in the treatment of respiratory diseases. Ulanova M; Schreiber AD; Befus AD BioDrugs; 2006; 20(1):1-11. PubMed ID: 16573347 [TBL] [Abstract][Full Text] [Related]
23. Multitargeted approach using antisense oligonucleotides for the treatment of asthma. Allakhverdi Z; Allam M; Guimond A; Ferrari N; Zemzoumi K; Séguin R; Paquet L; Renzi PM Ann N Y Acad Sci; 2006 Oct; 1082():62-73. PubMed ID: 17145927 [TBL] [Abstract][Full Text] [Related]
25. Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. Finotto S; Buerke M; Lingnau K; Schmitt E; Galle PR; Neurath MF J Allergy Clin Immunol; 2001 Feb; 107(2):279-86. PubMed ID: 11174194 [TBL] [Abstract][Full Text] [Related]
26. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Gauvreau GM; Boulet LP; Cockcroft DW; Baatjes A; Cote J; Deschesnes F; Davis B; Strinich T; Howie K; Duong M; Watson RM; Renzi PM; O'Byrne PM Am J Respir Crit Care Med; 2008 May; 177(9):952-8. PubMed ID: 18244953 [TBL] [Abstract][Full Text] [Related]
27. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases. Danis RP; Henry SP; Ciulla TA Expert Opin Pharmacother; 2001 Feb; 2(2):277-91. PubMed ID: 11336586 [TBL] [Abstract][Full Text] [Related]
28. In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Crooke RM Anticancer Drug Des; 1991 Dec; 6(6):609-46. PubMed ID: 1772572 [TBL] [Abstract][Full Text] [Related]
30. Cell membranes as barriers for the use of antisense therapeutic agents. Jääskeläinen I; Urtti A Mini Rev Med Chem; 2002 Aug; 2(4):307-18. PubMed ID: 12370052 [TBL] [Abstract][Full Text] [Related]